Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Does DGF Result in Worse Outcomes in a Second Transplant?
B. Muth,¹ B. Astor,^1,2 J. Blazel,¹ J. Turk,¹ D. Mandelbrot,¹ A. Djamali,¹ S. Parajuli.¹
¹Department of Medicine, University of Wisconsin, Madison, WI; ²Department of Population Health, University of Wisconsin, Madison, WI.
Delayed graft function (DGF) is a risk factor for patient death, kidney allograft loss, reduced allograft function and acute rejection after kidney transplantation. Prior transplant…
2018 American Transplant Congress
Pilot Study of Health IT Feasibility and Impact on Quality of Life for Young Adult Kidney Transplant Recipients
C. Blosser, R. Katz, J. Himmelfarb, N. Bansal.
Nephrology, University of Washington, Seattle, WA.
Background: Young adult kidney transplant recipients (KTRs) are an at-risk population and long-term survival rates are significantly lower than expected. A large majority of young…
2018 American Transplant Congress
Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation
S. Udomkarnjananun,¹ N. Townamchai,¹ K. Iampenkhae,² Y. Avihingsanon,¹ S. Eiam-Ong,¹ K. Praditpornsilpa.¹
¹Nephrology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ²Pathology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Delayed graft function (DGF) is considered as a risk factor for long-term allograft failure and rejection episodes.There is currently no biomarker in the immediate post-kidney…
2018 American Transplant Congress
Treatment of HCV Infection in Renal Transplant Recipients
M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.
Renal Transplant Unit, Instituto de Nefrologia Nephrology, Buenos Aires, Argentina.
HCV infection is associated to chronic hepatitis, cirrhosis, hepatic carcinoma and increased incidence of diabetes. Combination of new antiviral drugs have demonstrated utility in liver…
2018 American Transplant Congress
Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors
S. Armanyous, M. Lioudis, G. Thomas, E. Poggio, J. Augustine.
Nephrology, Cleveland Clinic, Cleveland, OH.
Background: Precise blood pressure (BP) measurement to exclude hypertension (HTN) is critical in evaluating living kidney donors (LKDs). 24-hour ambulatory blood pressure monitoring (ABPM) is…
2018 American Transplant Congress
The Technique of Ileobladder and Kidney Transplantation in Rats and Pigs
M. Haberal,¹ M. Kirnap,¹ D. Ersoz,¹ D. Bacanli,² Z. Ersoy,³ M. Bayzakov,¹ A. Torgay,³ H. Ozdemir.⁴
¹Transplantation, Baskent University, Ankara, Turkey; ²Research Center, Baskent University, Ankara, Turkey; ³Anesthesiology, Baskent University, Ankara, Turkey; ⁴Pathology, Baskent University, Ankara, Turkey.
Introduction: Small, poor compliant or unstable bladders are a major problem in patients waiting for renal transplantation (RT). The experimental technique aims to develop and…
2018 American Transplant Congress
Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes
S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.
¹Saarland University, Homburg/Saar, Germany; ²Saarland University, Homburg/Saar, Germany.
Background: Dosage of immunosuppressive drugs in transplant patients must be balanced to prevent graft rejection and infectious complications. Knowledge on general immune function may therefore…
2018 American Transplant Congress
Predicting Survival after Deceased-Donor Kidney Transplants by Donor-Recipient Match: Who Can Tolerate a High-KDPI Kidney?
S. Bae, J. Garonzik Wang, K. Jackson, A. Thomas, X. Luo, A. Massie, D. Segev.
Johns Hopkins School of Medicine, Baltimore, MD.
Deceased-donor kidney transplantation (DDKT) with high-KDPI kidneys carries an additional risk of mortality and graft failure, which could be tolerable for some candidates but detrimental…
2018 American Transplant Congress
The Impact of Rituximab Dose on Hepatitis B Virus Reactivation in HBsAg-Negative/anti-HBc-Positive Kidney Transplant Recipients
J. Lee,¹ J. Park,² Y. Jung,¹ D. Kim,¹ J. Lee,¹ S. Song,³ J. Lee,⁴ J. Lee,¹ B. Kim,⁵ M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
¹Surgery, Yonsei University College of Medicine, Seoul, Korea; ²Internal Medicine (Gastroenterology), Yonsei University College of Medicine, Seoul, Korea; ³Surgery, Ewha Womans University, School of Medicine, Seoul, Korea; ⁴Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea; ⁵Internal Medicine (Nephrology), Yonsei University College of Medicine, Seoul, Korea.
Background: Hepatitis B virus (HBV) reactivation is well-recognized complication of rituximab. Although use of rituximab for sensitized patients continues to increase in kidney transplantation, the…
2018 American Transplant Congress
Redo Kidney Transplant in FSGS
J. Verbesey, A. Javaid, S. Yi, G. Vranic, A. Gilbert, P. Abrams, S. Ghasemian, J. Moore, B. Thomas, M. Cooper, B. Javaid.
Kidney and Pancreas Transplant Program, MedStar Georgetown Transplant Institute, Washington, DC.
Objective: Analyze risk of graft failure due to recurrent FSGS in patients with prior failed kidney transplants under consideration for a subsequent transplant.Results: We identified…